Janus Henderson Investors US’s Regenxbio RGNX Stock Holding History

Janus Henderson Investors US’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-213,005	Closed	-$2.98M	–	1230
2016 Q3	$2.98M	Sell	213,005 -314,814	-60%	-$3.47M	﹤0.01%	896
2016 Q2	$4.22M	Buy	527,819 +308,956	+141%	+$3.43M	﹤0.01%	807
2016 Q1	$2.36M	Sell	218,863 -3,347	-2%	-$42.8K	﹤0.01%	891
2015 Q4	$3.69M	Sell	222,210 -63,682	-22%	-$1.26M	﹤0.01%	863
2015 Q3	$6.3M	Buy	+285,892	New	+$7.3M	0.01%	794

Other funds holding RGNX

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Janus Henderson Investors US's RGNX Position: Q4 2016 in Review

Janus Henderson Investors US sold out of Regenxbio (RGNX) in Q4 2016, closing a stake of 213,005 shares — an estimated $2.98M sold.

Janus Henderson Investors US first reported a position in RGNX in Q3 2015 and held it in 5 quarters. The position peaked at $6.3M in Q3 2015. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

Janus Henderson Investors US reported no remaining Regenxbio position as of Q4 2016 after selling out during the quarter.
Janus Henderson Investors US sold 213,005 Regenxbio shares in Q4 2016, an estimated $2.98M.
Janus Henderson Investors US first reported a position in Regenxbio in Q3 2015 and held it in 5 quarters.
Janus Henderson Investors US's Regenxbio position peaked at $6.3M in Q3 2015.
78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on Janus Henderson Investors US's 13F filing for Q4 2016, filed 14 Feb 2017.